Canopy Growth (CGC)
NASDAQ:CGC

Canopy Growth (CGC) Stock Price & Analysis

9,705 Followers

CGC Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.35 - $4.77
Previous Close$0.62
Volume30.90M
Average Volume (3M)49.94M
Market Cap
$460.69M
Enterprise Value$809.55M
Total Cash (Recent Filing)C$571.07M
Total Debt (Recent Filing)C$1.05B
Price to Earnings (P/E)-0.3
Beta2.09
Feb 15, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.81
Shares Outstanding829,083,667
10 Day Avg. Volume16,505,769
30 Day Avg. Volume49,935,689
Standard Deviation0.25
R-Squared0.12
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)1.07
Price to Sales (P/S)4.71
Price to Cash Flow (P/CF)-1.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
Price Target Upside-4.53% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering9


Financials

Annual

Ownership Overview

27.31% Insiders
0.72% Mutual Funds
7.29% Other Institutional Investors
64.68% Public Companies and Individual Investors

CGC FAQ

What was Canopy Growth’s price range in the past 12 months?
Canopy Growth lowest stock price was $0.35 and its highest was $4.77 in the past 12 months.
    What is Canopy Growth’s market cap?
    Currently, no data Available
    When is Canopy Growth’s upcoming earnings report date?
    Canopy Growth’s upcoming earnings report date is Feb 15, 2024 which is in 75 days.
      How were Canopy Growth’s earnings last quarter?
      Canopy Growth released its earnings results on Nov 09, 2023. The company reported -$0.315 earnings per share for the quarter, missing the consensus estimate of -$0.115 by -$0.2.
        Is Canopy Growth overvalued?
        According to Wall Street analysts Canopy Growth’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Canopy Growth pay dividends?
          Canopy Growth does not currently pay dividends.
          What is Canopy Growth’s EPS estimate?
          Canopy Growth’s EPS estimate is -$0.05.
            How many shares outstanding does Canopy Growth have?
            Canopy Growth has 829,083,700 shares outstanding.
              What happened to Canopy Growth’s price movement after its last earnings report?
              Canopy Growth reported an EPS of -$0.315 in its last earnings report, missing expectations of -$0.115. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Canopy Growth?
                Among the largest hedge funds holding Canopy Growth’s share is Maverick Capital ltd. It holds Canopy Growth’s shares valued at N/A.

                  ---

                  Company Description

                  Canopy Growth

                  Canopy Growth Corp. engages in the production and sale of medical cannabis. The company offers products including oils and concentrates, soft gel capsules and hemp. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

                  ---

                  Top 5 ETFs holding CGC

                  Currently, no data available
                  Please return soon. This page is being updated.
                  Up to five ETFs with an Outperform Smart Score that hold CGC. The ETFs are listed according to market value of CGC within the ETF

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Aurora Cannabis
                  Cronos Group
                  Tilray
                  Curaleaf Holdings

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis